Biogen Sets Aside Cash For Business Development, Expects New Launches In 2014
This article was originally published in The Pink Sheet Daily
Executive Summary
The spec pharma had a strong year and will continue to rely on new product launches going forward, but hopes to bolster its pipeline with early-stage add-ons.